Precision Medicine News and Updates | Precision Medicine Online
BMS third quarter revenues increased 8 percent to $11.90 billion, with its growth portfolio now making up half of total revenues. Amgen Sees Strong Growth for Precision Oncology Drugs in …
Breaking News - Precision Medicine Online
3 days ago · Viracta Therapeutics Cutting 42 Percent of Workforce, Reducing Board Seats in Restructuring. The restructuring is aimed at freeing up resources so the firm can advance its …
Precision Oncology News - Precision Medicine Online
Nov 8, 2024 · NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines. Nov 7, 2024. Gilead Sciences Focuses on New Multiple Myeloma CAR T Amid Flat Q3 Cell Therapy Sales. …
BRCA1/2 Mutations Aren't Equal: Researchers Push for Reduced …
10 hours ago · NEW YORK – The authors of a paper published this month want to establish reduced penetrance pathogenic variants (RPPVs) as a new category of BRCA1/2 variants …
Autoimmune Disease Research News - Precision Medicine Online
Jul 11, 2024 · Kyverna Therapeutics Gets FDA Permission to Study CAR T-Cell Therapy in Multiple Sclerosis. News on research and diagnostics in autoimmune disorders including …
EMA's CHMP Recommends Approval for First-Line Opdivo-Yervoy …
12 hours ago · NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use on Friday recommended approval of Bristol Myers Squibb's PD-1 …
Genomics Technology, Tools & Methods - Precision Medicine Online
Oct 29, 2024 · Sep 11, 2024. New Data Shore Up Evidence for Paired Tumor Origin, Molecular Testing in Cancer of Unknown Primary. Load More. The latest news on life science tools and …
Precision Oncology Precision Oncology News - Precision Medicine …
Oct 7, 2024 · The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.
Business & Financial News | Precision Medicine Online
Oct 28, 2024 · Ocuphire Pharma, Opus Genetics Merge in All-Stock Deal. Oct 23, 2024. Roche Sees Strong Demand for Elevidys Gene Therapy Amid Steady Q3 Pharmaceutical Revenue …
Genomics Research & Discovery | Precision Medicine Online
Oct 7, 2024 · Starting next year, the network will implement a population genomic screening pilot program for common, actionable genomic conditions in a primary care setting over five years. …